- Report
- March 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
Miglitol is a prescription drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as alpha-glucosidase inhibitors, which work by slowing the breakdown of carbohydrates in the intestines, thus reducing the amount of glucose absorbed into the bloodstream. Miglitol is typically used in combination with diet and exercise to help control blood sugar levels. It is also sometimes used in combination with other diabetes medications.
Miglitol is a key player in the Endocrine and Metabolic Disorders Drugs market, which includes a range of treatments for conditions such as diabetes, obesity, and thyroid disorders. These drugs are used to help regulate hormones and metabolism, and can be used to treat both acute and chronic conditions.
Notable companies in the Miglitol market include Merck & Co., Inc., Sanofi, Novo Nordisk, and Eli Lilly and Company. Show Less Read more